文献速递脑血管病外科

高级别脑动静脉畸形的立体定向放射外科治疗结局:系统综述与Meta分析

Outcomes following stereotactic radiosurgery for high-grade brain arteriovenous malformations: a systematic review and meta-analysis.
PubMed 文献 · J Neurosurg · 2025-02-07

该系统综述与Meta分析纳入15项研究、562例高级别(Spetzler-Martin IV-VI级)脑动静脉畸形,评估立体定向放射外科(SRS)后的闭塞率、不良放射效应(ARE)及出血率。中位随访50个月,总闭塞率34.2%(95%CI 27.0%-42.1%,I²=65.1%),SRS后出血率12.2%(95%CI 7.8%-18.7%,I²=25%),ARE总发生率9.3%(95%CI 5.2%-15.9%,I²=0%)。

要点

  • 高级别脑动静脉畸形SRS后中位随访50个月的总闭塞率为34.2%(95%CI 27.0%-42.1%)。
  • SRS后总出血率为12.2%;既往破裂AVM为12.7%,未破裂AVM为5.2%。
  • 不良放射效应(ARE)总发生率为9.3%(95%CI 5.2%-15.9%)。

核心结论

  • 高级别AVM的SRS治疗闭塞率有限,约9%的病例出现不良放射效应。
  • 既往破裂或具有高危血管构型特征的AVM患者可能更可能从该治疗中获益。

研究设计与样本

  • 系统综述与Meta分析,检索4个在线数据库,纳入15项研究、562例高级别(Spetzler-Martin IV-VI级)AVM。
  • 研究方案前瞻性注册于PROSPERO。

主要发现

  • 中位随访50个月,AVM总闭塞率为34.2%(95%CI 27.0%-42.1%,I²=65.1%)。
  • SRS后总出血率为12.2%(95%CI 7.8%-18.7%,I²=25%)。
  • 既往破裂AVM出血率为12.7%(95%CI 8.5%-18.7%,I²=0%),未破裂AVM为5.2%(95%CI 1.0%-23.1%,I²=0%)。
  • 不良放射效应(ARE)总发生率为9.3%(95%CI 5.2%-15.9%,I²=0%)。

临床怎么用

  • 作者认为,既往破裂或具有高危血管构型特征的高级别AVM患者可能更可能从SRS治疗中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Arteriovenous malformations (AVMs) of the brain are a leading cause of stroke in the young and carry a lifetime risk of intracerebral hemorrhage. The management options for high-grade AVMs are limited. Resection is often associated with high rates of postoperative morbidity, and the results of stereotactic radiosurgery (SRS) for these lesions thus far have been mixed. The aim of this study was to summate the published data on the outcomes of SRS for high-grade AVMs in order to better inform the management of these otherwise untreatable lesions. METHODS: A search of four online databases for literature pertaining to the use of SRS to treat high-grade (Spetzler-Martin grades IV-VI) AVMs was performed. Data pertaining to AVM obliteration, incidence of adverse radiation effects (AREs), and posttreatment hemorrhage were extracted, and a meta-analysis of proportions was performed. The study protocol was prospectively registered with PROSPERO. RESULTS: Fifteen studies describing the results of SRS treatment of 562 high-grade AVMs were analyzed. The overall rate of AVM obliteration during a median follow-up period of 50 months was 34.2% (95% CI 27.0%-42.1%, I2 = 65.1%). The pooled rate of hemorrhage following SRS treatment was 12.2% (95% CI 7.8%-18.7%, I2 = 25%). For previously ruptured AVMs, the rate of hemorrhage was 12.7% (95% CI 8.5%-18.7%, I2 = 0%) compared with 5.2% (95% CI 1.0%-23.1%, I2 = 0%) for unruptured AVMs. The overall incidence of AREs was 9.3% (95% CI 5.2%-15.9%, I2 = 0%). CONCLUSIONS: SRS for high-grade AVMs is associated with a modest rate of obliteration and is complicated by AREs in 9% of cases. Patients harboring previously ruptured AVMs or lesions with high-risk angioarchitectural features may be more likely to benefit from this treatment.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Farhad I, Ridzuan-Allen A, Ansari S, et al. Outcomes following stereotactic radiosurgery for high-grade brain arteriovenous malformations: a systematic review and meta-analysis. J Neurosurg. 2025. PMID: 39919274. doi:10.3171/2024.9.JNS241110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。